SIGA Technologies, Inc.

NasdaqGM:SIGA Stock Report

Market Cap: US$419.9m

SIGA Technologies Past Earnings Performance

Past criteria checks 3/6

SIGA Technologies has been growing earnings at an average annual rate of 21.8%, while the Pharmaceuticals industry saw earnings growing at 1.8% annually. Revenues have been growing at an average rate of 21% per year. SIGA Technologies's return on equity is 50.6%, and it has net margins of 49.3%.

Key information

21.8%

Earnings growth rate

24.1%

EPS growth rate

Pharmaceuticals Industry Growth6.0%
Revenue growth rate21.0%
Return on equity50.6%
Net Margin49.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Investors Shouldn't Be Too Comfortable With SIGA Technologies' (NASDAQ:SIGA) Earnings

Nov 15
Investors Shouldn't Be Too Comfortable With SIGA Technologies' (NASDAQ:SIGA) Earnings

Shareholders Can Be Confident That SIGA Technologies' (NASDAQ:SIGA) Earnings Are High Quality

Mar 19
Shareholders Can Be Confident That SIGA Technologies' (NASDAQ:SIGA) Earnings Are High Quality

Recent updates

SIGA Technologies Vs Emergent BioSolutions: Product Portfolio And Future Outlook

Dec 02

SIGA Technologies: Expansion Into mAbs Is Smart, But Eggs Remain In One Basket

Nov 21

Investors Shouldn't Be Too Comfortable With SIGA Technologies' (NASDAQ:SIGA) Earnings

Nov 15
Investors Shouldn't Be Too Comfortable With SIGA Technologies' (NASDAQ:SIGA) Earnings

SIGA Technologies, Inc. (NASDAQ:SIGA) Not Doing Enough For Some Investors As Its Shares Slump 34%

Sep 14
SIGA Technologies, Inc. (NASDAQ:SIGA) Not Doing Enough For Some Investors As Its Shares Slump 34%

SIGA Technologies: Shares Tanking On Mpox Study Miss, Turbulence May Be Temporary

Aug 15

SIGA Technologies, Inc. (NASDAQ:SIGA) Held Back By Insufficient Growth Even After Shares Climb 31%

Jul 14
SIGA Technologies, Inc. (NASDAQ:SIGA) Held Back By Insufficient Growth Even After Shares Climb 31%

SIGA Technologies: BARDA Contract Renewal Required To Sustain Recent Momentum (Rating Downgrade)

Jun 13

SIGA Technologies, Inc. (NASDAQ:SIGA) Stock Rockets 64% But Many Are Still Ignoring The Company

Mar 31
SIGA Technologies, Inc. (NASDAQ:SIGA) Stock Rockets 64% But Many Are Still Ignoring The Company

Siga Technologies: Preparing For A Contingency If Tomorrow Comes

Mar 25

Shareholders Can Be Confident That SIGA Technologies' (NASDAQ:SIGA) Earnings Are High Quality

Mar 19
Shareholders Can Be Confident That SIGA Technologies' (NASDAQ:SIGA) Earnings Are High Quality

The Price Is Right For SIGA Technologies, Inc. (NASDAQ:SIGA)

Feb 15
The Price Is Right For SIGA Technologies, Inc. (NASDAQ:SIGA)

Do SIGA Technologies' (NASDAQ:SIGA) Earnings Warrant Your Attention?

Jan 13
Do SIGA Technologies' (NASDAQ:SIGA) Earnings Warrant Your Attention?

SIGA Technologies secures new contract awarded to procure up to $10.7M of TPOXX

Sep 29

Siga monkeypox therapy undergoes NIH-led late-stage trial

Sep 09

Scientists behind key COVID study run monkeypox trial for SIGA therapy

Aug 23

SIGA to activate first trial sites for monkeypox therapy in U.K. next week – Bloomberg

Aug 17

Estimating The Fair Value Of SIGA Technologies, Inc. (NASDAQ:SIGA)

Aug 12
Estimating The Fair Value Of SIGA Technologies, Inc. (NASDAQ:SIGA)

SIGA to deliver $26M of monkeypox therapy to U.S. in 2023 after option exercise

Aug 09

SIGA Technologies: Unjustified Selloff, Loading The Boat, Best Monkeypox Play

Aug 01

SIGA Technologies: Buy Monkeypox

Jul 25

Siga Technologies receives approval from UK for tecovirimat

Jul 08

SIGA Technologies: Solid Business With Means To Address Monkeypox Outbreak

May 27

SIGA Technologies: There's An Assured Market For A Smallpox Vaccine

Dec 12

It's Probably Less Likely That SIGA Technologies, Inc.'s (NASDAQ:SIGA) CEO Will See A Huge Pay Rise This Year

Jun 08
It's Probably Less Likely That SIGA Technologies, Inc.'s (NASDAQ:SIGA) CEO Will See A Huge Pay Rise This Year

SIGA Technologies: Biodefense Pharma Unlocks New Value Abroad For TPOXX

Apr 28

Revenue & Expenses Breakdown

How SIGA Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGM:SIGA Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2417486260
30 Jun 2417384270
31 Mar 2415779260
31 Dec 2314068220
30 Sep 2335-5210
30 Jun 239828340
31 Mar 2310933360
31 Dec 2211134350
30 Sep 22215108330
30 Jun 2214772180
31 Mar 2213970180
31 Dec 2113469180
30 Sep 215616180
30 Jun 219544170
31 Mar 2112764150
31 Dec 2012556150
30 Sep 209132140
30 Jun 20556140
31 Mar 2019-18130
31 Dec 1927-7130
30 Sep 192450140
30 Jun 19487439140
31 Mar 19486435130
31 Dec 18477422130
30 Sep 18477359120
30 Jun 187-39120
31 Mar 189-39120
31 Dec 1712-36120
30 Sep 1718-36130
30 Jun 1721-36130
31 Mar 1719-38140
31 Dec 1615-40140
30 Sep 1612-49120
30 Jun 169-46110
31 Mar 168-43100
31 Dec 158-39110
30 Sep 155-38100
30 Jun 155-273120
31 Mar 154-269130
31 Dec 143-265130
30 Sep 143-251140
30 Jun 144-16130
31 Mar 145-16130

Quality Earnings: SIGA has a high level of non-cash earnings.

Growing Profit Margin: SIGA became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: SIGA's earnings have grown significantly by 21.8% per year over the past 5 years.

Accelerating Growth: SIGA has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: SIGA has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (61.2%).


Return on Equity

High ROE: SIGA's Return on Equity (50.6%) is considered outstanding.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 01:43
End of Day Share Price 2025/02/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

SIGA Technologies, Inc. is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason KolbertB. Riley Wealth
Soo RomanoffEdison Investment Research
Nancy HullLadenburg Thalmann & Company